The WHO estimates the average medication adherence rate is 50% in developed nations, though the U.S. trails other countries in reported adherence on Medisafe.…


Pfizer wins EU label expansion for MenACWY vaccine Nimenrix

Pfizer, BMS loan Portola $50M to help deal with CRL for antibleeding agent AndexXa

Clovis set to challenge AZ with early PARP approval Rubraca

Playing in vaccines could have its perks in 2017's price-pressured climate

Pfizer finally convinces FDA to pull black-box warning on Chantix for psychotic side effects

For Inflectra launch, Pfizer uses 'hybrid model' to home in on HCPs

FiercePharmaAsia: Japan’s drug pricing review, Pfizer’s Pakistan plant, and Perrigo’s API plant sale

Xtandi, cornerstone of Pfizer's $14B Medivation buy, falls short in closely watched study

Pfizer wins quick reward from buyout of Anacor with approval of eczema drug expected to be blockbuster

Pfizer trying to sell Pakistan plant